Promotion of fas-mediated apoptosis in type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement

Journal of Cellular Physiology

Volumn 213, Issue 2, 2007, Pages 556-563

  Zhao, Yongge ^a,b   Difrancesca, Daniell ^a   Wang, Xue ^a   Zarnegar, Reza ^a   Michalopoulos, George K ^a   Yin, Xiao Ming ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2; PROTEIN BCL X; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; IN VIVO STUDY; LIVER INJURY; LIVER MITOCHONDRION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 8; CELL LINE; ENZYME ACTIVATION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; LIVER; MICE; MICE, KNOCKOUT; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 34848857642     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21136     Document Type: Article

References (29)

1. Ashkenazi A, Dixit VM. 1998. Death receptors: Signaling and modulation. Science 281:1305-1308.
2. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, Weissberg P. 1998. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis. Science 282:290-293.
3. Conner EA, Teramoto T, Wirth PJ, Kiss A, Garfield S, Thorgeirsson SS. 1999. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis 20:583-590.
4. de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, Perret C, Kahn A, Mignon A. 1999. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol Gastrointest Liver Physiol 277:G702-G708.
5. Du C, Fang M, Li Y, Li L, Wang X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42.
6. Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science 305:626-629.
7. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ. 1999. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156-1163.
8. Huh C-G, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. 2004. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. PNAS 101:4477-4482.
9. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S. 1998. Caspase-independent cell killing by fas-associated protein with death domain. J Cell Biol 143:1353-1360.
10. Khai NC, Takahashi T, Ushikoshi H, Nagano S, Yuge K, Esaki M, Kawai T, Goto K, Murofushi Y, Fujiwara T, Fujiwara H, Kosai K-I. 2006. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: A comparative study to HGF. J Hepatol 44:1046-1054.
11. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. 1998. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244:683-690.
12. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2:80-86.
13. Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S, Peter ME, Chan AC. 2006. The role of receptor internalization in CD95 signaling. EMBO J 25:1009-1023.
14. Li S, Zhao Y, He X, Kim T-H, Kuharsky DK, Rabinowich H, Chen J, Du C, Yin X-M. 2002. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem 277:26912-26920.
15. Matteucci E, Modora S, Simone M, Desiderio MA. 2003. Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: Favouring role of hypoxia-inducible factor-1 deficiency. Oncogene 22:4062-4073.
16. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, Nagata S. 1994. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 215:332-337.
17. Rasola A, Anguissola S, Ferrero N, Gramaglia D, Maffe A, Maggiora P, Comoglio PM, Di Renzo MF. 2004. Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin. Cancer Res 64:1744-1750.
18. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675-1687.
19. Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas SC, Frey CR, Dax A, Zink D, Buchler P, Muller M, Krammer PH. 2004. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 39:645-654.
20. Smyth LA, Brady HJ. 2005. cMet and Fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells. Hypertension 46:100-106.
21. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ. 2000. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 278:G992-G999.
22. Sun XM, Bratton SB, Butterworth M, MacFarlane M, Cohen GM. 2002. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem 277:11345-11351.
23. Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, Shiraki K. 2000. Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32:796-802.
24. Takehara T, Tatsumi T, Suzuki T, Rucker EB, Hennighausen L, Jinushi M, Miyagi T, Kanazawa Y, Hayashi N. 2004. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 127:1189-1197.
25. Wang X, DeFrances MC, Dai Y, Pediaditakis P, Johnson C, Bell A, Michalopoulos GK, Zarnegar R. 2002. A mechanism of cell survival: Sequestration of Fas by the HGF receptor Met. Mol Cell 9:411-421.
26. Yang J, Chen S, Huang L, Michalopoulos GK, Liu Y. 2001. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology 33:848-859.
27. Yip XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ. 1999. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400:886-891.
28. Zhao Y, Li S, Childs EE, Kuharsky DK, Yin X-M. 2001. Activation of Pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-alpha-induced liver injury. J Biol Chem 276:27432-27440.
29. Zhao Y, Ding WX, Qian T, Watkins S, Lemasters JJ, Yin XM. 2003. Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 125:854-867.